High Low Biphasic Energy Defibrillation (HiLoBED)
A Multicentre Prospective Randomised Study Comparing the Efficacy of High Versus Low Biphasic Energy Defibrillation in Patients With Cardiac Arrest
Sponsor: Changi General Hospital
Listed as NCT00429611, this PHASE3 trial focuses on Ventricular Fibrillation and remains ongoing. Sponsored by Changi General Hospital, it has been updated 5 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Nov 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Changi General Hospital
- Medtronic
- National Heart Centre Singapore
- National Medical Research Council (NMRC), Singapore
- National University Hospital, Singapore
- Singapore General Hospital
- Tan Tock Seng Hospital
For direct contact, visit the study record on ClinicalTrials.gov .